ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 443029 | 3-year financial timeline | COVID resilience: 43/100
🛡️ Public data only — no PHI permitted on this instance.
$28M
Latest Revenue (FY2022)
+2.2%
Revenue CAGR (3yr)
14.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $27M | $27M | $28M | +6.0% | +2.2% |
| Operating Expenses | $22M | $22M | $24M | +9.8% | +5.8% |
| Operating Margin | 20.5% | 17.8% | 14.8% | -16.5% | -15.0% |
| Net Income | $6M | $5M | $4M | -11.5% | -13.1% |
| Licensed Beds | 80 | 80 | 80 | +0.0% | +0.0% |
| Total Patient Days | 18,506 | 18,422 | 18,720 | +1.6% | +0.6% |
| Medicare Day % | 50% | 47% | 48% | +2.0% | -2.0% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 43/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +4.4% ($27M → $28M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.2%
This Hospital
+7.6%
State Avg
Latest Margin
14.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | 12.0% |
| FY2024 (proj) | $30M | 9.2% |
| FY2025 (proj) | $30M | 6.3% |